Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells
Recurrence of advanced epithelial ovarian cancer is common despite optimal surgical debulking and initial favorable responses to chemotherapy. Evidences suggest that cancer stem cells (CSCs) have inherent resistance to conventional therapies such as chemotherapy and play a decisive role in cancer re...
Main Authors: | Chih-Long Chang, Chao-Chih Wu, Yun-Ting Hsu, Yi-Chiung Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1803530 |
Similar Items
-
Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
by: Lan Yu, et al.
Published: (2021-12-01) -
CD47—a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features
by: Xukai Luo, et al.
Published: (2024-02-01) -
Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity
by: Albin Jeanne, et al.
Published: (2021-10-01) -
Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
by: Hongcheng Yang, et al.
Published: (2019-08-01) -
Expression of CRT and CD47 in Gastric Carcinoma and Their Significance
by: SUN Ke, et al.
Published: (2019-01-01)